WallStreetZenWallStreetZen

NASDAQ: HOLX
Hologic Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HOLX

Based on 10 analysts offering 12 month price targets for Hologic Inc

Min Forecast
$82.00+8.84%
Avg Forecast
$89.40+18.66%
Max Forecast
$95.00+26.1%

Should I buy or sell HOLX stock?

Based on 10 analysts offering ratings for Hologic Inc.

Buy
Strong Buy
2 analysts 20%
Buy
4 analysts 40%
Hold
4 analysts 40%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HOLX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates HOLX as a "Hold". Stocks with a Zen Rating of Hold have beat the market by +7.53%. Learn More

Be the first to know when Wall Street analysts revise their HOLX stock forecasts and price targets.

HOLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-05
lockedlocked$00.00+00.00%2024-11-05
lockedlocked$00.00+00.00%2024-11-05
lockedlocked$00.00+00.00%2024-11-05
lockedlocked$00.00+00.00%2024-11-05
Needham
Top 25%
76
BuyReiterates$90.00+19.46%2024-10-15
Leerink Partners
Bottom 2%
2
BuyMaintains$90.00+19.46%2024-10-08
Evercore ISI Group
Bottom 8%
8
HoldMaintains$82.00+8.84%2024-10-01
Citigroup
Top 17%
84
HoldDowngrades$85.00+12.82%2024-10-01
Stephens & Co.
Top 31%
70
Strong BuyReiterates$92.00+22.11%2024-07-30

1 of 1

Forecast return on equity

Is HOLX forecast to generate an efficient return?

Company
22.31%
Industry
9.85%
Market
70.65%
HOLX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HOLX forecast to generate an efficient return on assets?

Company
12.5%
Industry
5.49%
HOLX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HOLX earnings per share forecast

What is HOLX's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$4.28+27.87%
Avg 2 year Forecast
$4.68+39.74%
Avg 3 year Forecast
$5.04+50.55%
HOLX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

HOLX revenue forecast

What is HOLX's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$4.2B+3.64%
Avg 2 year Forecast
$4.4B+9.8%
Avg 3 year Forecast
$4.7B+15.8%
HOLX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HOLX earnings growth forecast

How is HOLX forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
14.7%
Industry
19.18%
Market
17.31%
HOLX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
HOLX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
HOLX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

HOLX revenue growth forecast

How is HOLX forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
5.03%
Industry
8.01%
Market
8.88%
HOLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HOLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HOLX vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
HOLX$75.34$89.40+18.66%Buy
BAX$31.80$39.29+23.54%Hold
COO$98.70$115.71+17.24%Strong Buy
ATR$171.15$195.00+13.94%Strong Buy
WST$322.49N/AN/A
View Top Medical Stocks

Hologic Stock Forecast FAQ

Is Hologic Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: HOLX) stock is to Buy HOLX stock.

Out of 10 analysts, 2 (20%) are recommending HOLX as a Strong Buy, 4 (40%) are recommending HOLX as a Buy, 4 (40%) are recommending HOLX as a Hold, 0 (0%) are recommending HOLX as a Sell, and 0 (0%) are recommending HOLX as a Strong Sell.

If you're new to stock investing, here's how to buy Hologic stock.

What is HOLX's earnings growth forecast for 2025-2027?

(NASDAQ: HOLX) Hologic's forecast annual earnings growth rate of 14.7% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 19.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.31%.

Hologic's earnings in 2024 is $789,500,000.On average, 8 Wall Street analysts forecast HOLX's earnings for 2025 to be $972,170,785, with the lowest HOLX earnings forecast at $964,500,172, and the highest HOLX earnings forecast at $982,655,470. On average, 8 Wall Street analysts forecast HOLX's earnings for 2026 to be $1,062,379,919, with the lowest HOLX earnings forecast at $1,023,504,889, and the highest HOLX earnings forecast at $1,080,240,193.

In 2027, HOLX is forecast to generate $1,144,532,640 in earnings, with the lowest earnings forecast at $1,121,089,612 and the highest earnings forecast at $1,171,016,680.

What is HOLX's revenue growth forecast for 2025-2027?

(NASDAQ: HOLX) Hologic's forecast annual revenue growth rate of 5.03% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.88%.

Hologic's revenue in 2024 is $4,030,300,000.On average, 6 Wall Street analysts forecast HOLX's revenue for 2025 to be $947,930,059,291, with the lowest HOLX revenue forecast at $946,390,263,133, and the highest HOLX revenue forecast at $949,481,202,509. On average, 6 Wall Street analysts forecast HOLX's revenue for 2026 to be $1,004,283,421,473, with the lowest HOLX revenue forecast at $998,518,660,678, and the highest HOLX revenue forecast at $1,009,071,427,269.

In 2027, HOLX is forecast to generate $1,059,161,211,861 in revenue, with the lowest revenue forecast at $1,050,864,921,792 and the highest revenue forecast at $1,067,772,496,340.

What is HOLX's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: HOLX) forecast ROA is 12.5%, which is higher than the forecast US Medical Instruments & Supplies industry average of 5.49%.

What is HOLX's Price Target?

According to 10 Wall Street analysts that have issued a 1 year HOLX price target, the average HOLX price target is $89.40, with the highest HOLX stock price forecast at $95.00 and the lowest HOLX stock price forecast at $82.00.

On average, Wall Street analysts predict that Hologic's share price could reach $89.40 by Nov 5, 2025. The average Hologic stock price prediction forecasts a potential upside of 18.66% from the current HOLX share price of $75.34.

What is HOLX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: HOLX) Hologic's current Earnings Per Share (EPS) is $3.35. On average, analysts forecast that HOLX's EPS will be $4.28 for 2025, with the lowest EPS forecast at $4.25, and the highest EPS forecast at $4.33. On average, analysts forecast that HOLX's EPS will be $4.68 for 2026, with the lowest EPS forecast at $4.51, and the highest EPS forecast at $4.76. In 2027, HOLX's EPS is forecast to hit $5.04 (min: $4.94, max: $5.16).

What is HOLX's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: HOLX) forecast ROE is 22.31%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.